Pregnancy Poses Challenges to MS Management, Review Study Shows

Pregnancy Poses Challenges to MS Management, Review Study Shows

314489

Pregnancy Poses Challenges to MS Management, Review Study Shows

Women with multiple sclerosis (MS) who receive high-efficacy disease-modifying therapies (DMTs) before conception have a greater risk of relapses and disability progression during pregnancy than those given moderate-efficacy or no DMTs, according to a systematic review of studies. Exclusive breastfeeding for at least two to four months, however, was associated with a significantly lower risk of relapses after delivery. The findings suggest that a decision regarding DMT use “before, during, and after pregnancy for treating…

You must be logged in to read/download the full post.